Literature DB >> 2581508

Nucleotide metabolism and cellular damage in myocardial ischemia.

R B Jennings, C Steenbergen.   

Abstract

Adenine nucleotide metabolism is greatly altered by myocardial anoxia or ischemia, both of which induce depletion of ATP and of the total adenine nucleotide pool. The depletion occurs at variable rates depending upon the nature of the model and the severity and conditions of the injury. In ischemia, the decrease in both ATP and the adenine nucleotide pool is due to an inadequate rate of production of high-energy phosphate relative to the demand of the heart for energy. In the process of capturing the high-energy phosphate of ADP, AMP is produced via myokinase and is degraded to nucleosides and ultimately to bases. In the early phase of ischemia, ADO and INO are the chief metabolites produced. A small quantity of XAN and large quantities of HX accumulate with time until eventually HX replaces INO as the principal metabolite of the pool. The biology of myocardial ischemic cell damage in the dog heart is summarized with respect to the depletion of ATP and total adenine nucleotide pool. Myocytes can survive with about 25% of the ATP of control tissue but exhibit a variety of defects that persist for minutes to days. At the onset of irreversibility, the dead tissue invariably exhibits virtually no ATP and a 65% or greater depletion in the total adenine nucleotide pool. It is not known whether these changes in ATP and the pool are directly or indirectly related to the development of irreversibility. In any event, the transition to cell death appears to be gradual.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581508     DOI: 10.1146/annurev.ph.47.030185.003455

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  39 in total

Review 1.  The ubiquitin-proteasome system and cardiovascular disease.

Authors:  Saul R Powell; Joerg Herrmann; Amir Lerman; Cam Patterson; Xuejun Wang
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Hypoxia and glucose independently regulate the beta-adrenergic receptor-adenylate cyclase system in cardiac myocytes.

Authors:  K J Rocha-Singh; N Y Honbo; J S Karliner
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 3.  Mitochondria and cardioprotection.

Authors:  Fabio Di Lisa; Marcella Canton; Roberta Menabò; Nina Kaludercic; Paolo Bernardi
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

4.  Effects of different rates of cardiac pacing on rat myocardial energy status.

Authors:  C Montgomery; N Hamilton; C D Ianuzzo
Journal:  Mol Cell Biochem       Date:  1991-04-10       Impact factor: 3.396

Review 5.  The ubiquitin-proteasome system in myocardial ischaemia and preconditioning.

Authors:  Saul R Powell; Andras Divald
Journal:  Cardiovasc Res       Date:  2009-09-30       Impact factor: 10.787

6.  Autophagic adaptations in diabetic cardiomyopathy differ between type 1 and type 2 diabetes.

Authors:  Hiromitsu Kanamori; Genzou Takemura; Kazuko Goto; Akiko Tsujimoto; Atsushi Mikami; Atsushi Ogino; Takatomo Watanabe; Kentaro Morishita; Hideshi Okada; Masanori Kawasaki; Mitsuru Seishima; Shinya Minatoguchi
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

Review 7.  Proteasome functional insufficiency in cardiac pathogenesis.

Authors:  Xuejun Wang; Jie Li; Hanqiao Zheng; Huabo Su; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-23       Impact factor: 4.733

Review 8.  The mitochondrial permeability transition pore and its role in cell death.

Authors:  M Crompton
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

Review 9.  Purine metabolism in the heart. Strategies for protection against myocardial ischaemia.

Authors:  K Ver Donck
Journal:  Pharm World Sci       Date:  1994-04-15

10.  Possible direct role of reactive oxygens in the cause of cutaneous phototoxicity induced by five quinolones in mice.

Authors:  N Wagai; K Tawara
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.